
Precipio Investor Relations Material
Latest events

Q2 2025
Precipio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Precipio Inc
Access all reports
Precipio, Inc., a cancer diagnostics and reagent technology company, provides diagnostic products and services in the United States oncology market. The company delivers liquid biopsy products for the detection of genomic biomarkers, such as cell-free DNA (cfDNA) extracted from patient blood. Its integrated liquid biopsy platform combines proprietary CFDNA extraction and enrichment technology with third party sample preparation to enable the detection of tumor-specific cfDNA in multiple end-user clinical applications. The company is also involved in development of novel diagnostic products at its laboratories in Tempe and San Diego, California. Precipio, Inc. is based in San Diego, California.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
PRPO
Country
🇺🇸 United States